Quebec RNA Hub’s Academic Sector Survey

Question, comment or request for assistance ? Please write to Samuel Martin, webmaster, at samuel.martin@axelys.ca

Quebec RNA Hub’s Academic Sector Survey

"*" indicates required fields

Step 1 of 5

20%

This survey is intended for members of the network and the research community with the hope of collecting detailed information associated with RNA researchers in Quebec.

our contribution to this survey is therefore essential, as it will enable actors in the academic and industrial sectors to effectively reach researchers via AReNA, Quebec’s RNA Hubr.

By bringing together the best available data from RNA researchers in Quebec on a single portal, the desired objective is to improve the search for information on the RNA ecosystem, facilitate networking between individuals, public organizations and players in the life sciences and health technologies (LSHT) industry, and generate collaborations, partnerships and technology transfers.

Thank you for participating to the creation of Quebec’s RNA researchers academic sector!

Consent to participate in the survey*

By participating in this survey, you confirm that you have read and understood AReNA’s Privacy Policy.

Yes, I accept the conditions outlined in the Privacy Policy and I wish to participate in the survey.

Email address*

Curriculum Vitae

The survey is designed to be quick and easy to complete. In this context, sharing your Canadian Common CV (CCV) would significantly speed up the completion of this form. Your CCV contains a great deal of relevant and strategic information about your expertise.

Your CCV is available on the Government of Canada portal at https://ccv-cvc.ca/indexresearcher-fra.frm and you are the owner of the information it contains – you have the right to share it.

Please ensure that your CCV is up to date before exporting it in PDF format and uploading it to this form.

Do you wish to share your CCV (Canadian Common CV) with AReNA ?*

Yes, I wish to share my CCV

No, I do not wish to share my CCV but I want to answer the survey.

Upload your CCV (Canadian Common CV)*

Please upload your CCV as a .pdf

Accepted file types: pdf, Max. file size: 36 MB.

General Information

First Name and Last Name*

First Name Last Name (Family Name)

Position and Affiliations

Please list the positions you currently hold, as well as the institutions or organizations where you hold the position. Click on the + symbol to add positions.

Position

Institution ou organization

Diplomas and Certificates

Please use the text field or ordered fields below to indicate year of graduation, level (Master's, Doctorate) and discipline (Chemistry, Biology, etc.)

Diplomas et Certificates – Ordered fields

Click on the + symbol to add a diploma or certificate.

Year

Diploma or Certificate

Discipline

Expert Profile

As of June 2024, are you a director of at least one organization that aims to mobilize, represent and support the scientific community in the field of RNA?*

Yes

Prefer not to answer / Not applicable

Please provide details from organization(s), as of 2024.

Name of organization

Number of academic members

Number of industrial members

Research Domains and Expertise

What are you research domains or subdomains?

Please select all that apply.

Angiogenesis

Bioinformatics

Biomaterials

RNA Biotechnologies

Cancer

Carbohydrates

Cell biology

Chemical biology

Chemical modification of RNA

Computational biology

Data science

Drugs

Engineering

Enzymes

Epidemiology and public health

Food industry

Gene editing

Gene therapy

Health law

Identity and health equity

Immunological chemistry

Immunotherapy

Infectious diseases

Intellectual property

Lipids

Long non-coding RNAs

Machine learning or artificial intelligence

Metabolic diseases

Metabolism

Molecular biology

Nanomedicine

Nanotechnology

Nervous system diseases

Non-viral vectors

Nucleic acids

Nucleosides, nucleotides and oligonucleotides

Oncolytic viruses

Parasitology

Pediatric neurology

Physiology

Polymer chemistry

Proteins, peptides and amino acids

Rare diseases

Receptors

Regenerative medicine

Ribozymes or Riboswitch

RNA interference

RNA metabolism

RNA regulation

RNA splicing and processing

RNA structure and function

RNA synthesis

RNA viruses

RNA-based therapeutics

RNA-protein interactions

Stem cells

Structural biology

Synthetic biology

Therapies and vaccines

Tissue engineering

Translational research

Vaccinology

Vascular biology

Viral vectors for RNA delivery

Virology

Zoonotic diseases

What are your areas of expertise?

Please select all that apply.

Aging and age-related diseases

Antibody engineering

Antisense oligonucleotides

Aptamers

Biomarker discovery

Biomarkers in oncology

Cancer immunotherapy

Cell culture techniques

Chronic inflammatory diseases

CRISPR/Cas9 gene editing

Drug delivery systems

Gene expression analysis

Genetic diseases

High-throughput screening

Human genetics

Immunohistochemistry

In vitro testing

In vivo models

Lung diseases

Micro RNA

Molecular cloning

Nanoparticle synthesis

Nanoparticles

Neurodegenerative diseases

Neuroinflammation

Neurological disorders

Nucleic acid sequencing

Nutritional interventions in disease

Pathogenesis of complex diseases

Personalized medicine

Protein purification

Proteomics

Rare genetic syndromes

Real-time PCR

RNA degradation

RNA Interneference

RNA modulation for disease treatment

RNA-based diagnostics

Single cell sequencing

SiRNA

Small activating RNA

Stem cell-based regenerative therapies

Structural biology

Systems biology

Target validation

Therapeutic drug development

Tissue culture

Tissue repair and regeneration

Vaccine development

Viral diseases

Viral vector engineering

Virus-host interactions

Western blotting

Whole genome sequencing

Xenograft models

Xenotransplantation

Vesicular transport

If your research domain(s) or expertise is not provided above, please add it below:

Technology Platforms

What are the cutting-edge tools, infrastructures or technological platforms for which…

… you are responsible?

Select all choices that apply.

Automated laboratory systems

Bioprinting

CRISPR-Cas9 platforms

Drug discovery platforms

Gene editing technologies

Gene synthesis technologies

Genomic databases

Genomic technologies

In vivo imaging systems

In vivo models

Lab-on-a-chip devices

Metabolomics technologies

Microarray platforms

Microscopy technologies

Nanomaterials for drug delivery

Next-generation sequencing (NGS)

Organ-on-a-chip

Portable health monitoring systems

Proteomics technologies

Synthetic biology platforms

Tissue engineering platforms

Viral vector systems

Other

Please specify:

… you have access but are not responsible ?

Select all choices that apply.

Automated laboratory systems

Bioprinting

CRISPR-Cas9 platforms

Drug discovery platforms

Gene editing technologies

Gene synthesis technologies

Genomic databases

Genomic technologies

In vivo imaging systems

In vivo models

Lab-on-a-chip devices

Metabolomics technologies

Microarray platforms

Microscopy technologies

Nanomaterials for drug delivery

Next-generation sequencing (NGS)

Organ-on-a-chip

Portable health monitoring systems

Proteomics technologies

Synthetic biology platforms

Tissue engineering platforms

Viral vector systems

Other

Please specify:

… you have expertise but no immediate access?

Select all choices that apply.

Automated laboratory systems

Bioprinting

CRISPR-Cas9 platforms

Drug discovery platforms

Gene editing technologies

Gene synthesis technologies

Genomic databases

Genomic technologies

In vivo imaging systems

In vivo models

Lab-on-a-chip devices

Metabolomics technologies

Microarray platforms

Microscopy technologies

Nanomaterials for drug delivery

Next-generation sequencing (NGS)

Organ-on-a-chip

Portable health monitoring systems

Proteomics technologies

Synthetic biology platforms

Tissue engineering platforms

Viral vector systems

Other

Please specify:

Publications

Please provide a list of your publications. If you previously agreed to share your CCV, you may list more publications here.

Training

Do you provide training relevant to RNA-based therapies?

Yes

Not applicable

How many persons have you trained, as of June 2024 ?

Do you get training relevant to RNA-based therapies?

Yes

Not applicable

Please provide details on the training you have undertaken (year, title…)

Developed or Patented RNA Technologies

Please do not disclose any confidential information in the section below.

Have you developed a technology relevant to RNA-based therapies, as of June 2024 ?

Yes

Not applicable

How many technologie shave you developed, as of June 2024?

Please provide the title and descrtiption of those technologies. Do not disclose confidential information.

Title

Description

Patent number (if applicable)

Which of your technologies have reached TRL 4, as of June 2024?

Which of your technologies are in a clinical trial phase, as of June 2024?

Which of your technologies have been licensed / adopted, as of June 2024?

Which of your technologies have been commercialized, as of June 2024?

Please provide a name or a brief description. Click on + to add an item.

Collaborations and partnerships

Have you realized projects in partnership / collaboration with industry?

Yes

Do you have one or more currently ongoing project with industry?

Yes

If you have research projects that you would like to promote, please provide some details:

The AReNA team will contact you to discuss available options for implementing communication strategies.

Project Title

Principal Investigator

Industrial Partner

Funding and Revenues

Do you receive government funding (grants, subsidies, etc.) AND/OR private funding aimed at supporting the commercialization of RNA therapeutics technologies, as of June 2024?

Yes

Using the ordered fields or the free text area below, please share a few details with us. All fields are optional. Please do not share confidential information.

Organization

Project

Amount

Recipient

Academic Co-applicant

Industrial Co-applicant in Quebec

Industrial Co-applicant outside Quebec

Distribution of funding between parties

Please use this text box to share details of scholarships, grants or funding.

Suggested information: -Organization -Project -Amount -Recipients -Academic co-applicants -Industrial co-applicants in Quebec -Industrial co-applicants outside Quebec -Distribution of funding between the various parties (if shareable)

Do you generate revenue from RNA Therapeutics?

Yes

Prefer not to answer / Not applicable

Please define the type of revenue you generate from RNA Therapeutics

Select all relevant answers.

Licence revenue

Royalty revenue

Revenue from personal services

Other

Please specify the other type of revenue:

Please provide the range of revenue you generate from RNA Therapeutics, as of June 2024.

Less than $250 000

From $250 000 to $499 999

From $500 000 to $999 999

From $1 000 000 to $2 999 999

From $3 000 000 to $4 999 999

From $5 000 000 to $9 999 999

$10 000 000 or more

Last page of the survey

Which organization sent you this survey ?

AReNA

ARN Québec

Axelys

BIOQuébec

CASTL

CQDM

D2R

Montréal Invivo

Other

Please specify

Subscription to AReNA's newsletter

Yes, I which to subscribe to the newsletter from AReNA, Quebec’s RNA Hub.

Click on Submit survey answers below to complete this survey.

Name

This field is for validation purposes and should be left unchanged.

Question, comment or request for assistance ? Please write to Samuel Martin, webmaster, at samuel.martin@axelys.ca

Stay up to date with the latest news on RNA therapies

Email(Required)

Untitled(Required)

Yes, I agree to receive emails from AReNA. I understand that I can withdraw my consent at any time.

CAPTCHA